1.
Isbagio H. Use of anti-citrullinated peptide (Anti–CCP) antibodies in distinguishing patients with systemic lupus erythematosus and rheumatoid arthritis. Med J Indones [Internet]. 2004Nov.1 [cited 2022Jan.29];13(4):227-31. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/157